260 related articles for article (PubMed ID: 30204307)
1. Dorsal hypothalamic dopaminergic neurons play an inhibitory role in the hypothalamic-pituitary-adrenal axis via activation of D2R in mice.
Di T; Chen P; Yuan Z; Wang Y; Sha S; Chen L
Acta Physiol (Oxf); 2019 Feb; 225(2):e13187. PubMed ID: 30204307
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic afferents from midbrain to dorsolateral bed nucleus of stria terminalis inhibit release and expression of corticotropin-releasing hormone in paraventricular nucleus.
Di T; Wang Y; Zhang Y; Sha S; Zeng Y; Chen L
J Neurochem; 2020 Jul; 154(2):218-234. PubMed ID: 32096869
[TBL] [Abstract][Full Text] [Related]
3. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus.
Ginsberg AB; Campeau S; Day HE; Spencer RL
J Neuroendocrinol; 2003 Nov; 15(11):1075-83. PubMed ID: 14622438
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat.
Takemura T; Makino S; Takao T; Asaba K; Suemaru S; Hashimoto K
Brain Res; 1997 Sep; 767(2):181-91. PubMed ID: 9367246
[TBL] [Abstract][Full Text] [Related]
6. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
7. Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response.
Petrie GN; Balsevich G; Füzesi T; Aukema RJ; Driever WPF; van der Stelt M; Bains JS; Hill MN
Br J Pharmacol; 2023 Dec; 180(24):3146-3159. PubMed ID: 37482931
[TBL] [Abstract][Full Text] [Related]
8. Relaxin-3/RXFP3 signalling in mouse hypothalamus: no effect of RXFP3 activation on corticosterone, despite reduced presynaptic excitatory input onto paraventricular CRH neurons in vitro.
Zhang C; Baimoukhametova DV; Smith CM; Bains JS; Gundlach AL
Psychopharmacology (Berl); 2017 Jun; 234(11):1725-1739. PubMed ID: 28314951
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Hypothalamic NMDA Receptor Activity Contributes to Hyperactivity of HPA Axis in Chronic Stress in Male Rats.
Zhou JJ; Gao Y; Zhang X; Kosten TA; Li DP
Endocrinology; 2018 Mar; 159(3):1537-1546. PubMed ID: 29390057
[TBL] [Abstract][Full Text] [Related]
10. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
11. Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.
Wang LA; de Kloet AD; Smeltzer MD; Cahill KM; Hiller H; Bruce EB; Pioquinto DJ; Ludin JA; Katovich MJ; Raizada MK; Krause EG
Neuropharmacology; 2018 May; 133():85-93. PubMed ID: 29360543
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
[TBL] [Abstract][Full Text] [Related]
13. Acute stress diminishes M-current contributing to elevated activity of hypothalamic-pituitary-adrenal axis.
Zhou JJ; Gao Y; Kosten TA; Zhao Z; Li DP
Neuropharmacology; 2017 Mar; 114():67-76. PubMed ID: 27908768
[TBL] [Abstract][Full Text] [Related]
14. Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation.
Newsom RJ; Garcia RJ; Stafford J; Osterlund C; O'Neill CE; Day HEW; Campeau S
Psychoneuroendocrinology; 2020 Mar; 113():104549. PubMed ID: 31884322
[TBL] [Abstract][Full Text] [Related]
15. Endogenous oxytocin inhibits hypothalamic corticotrophin-releasing hormone neurones following acute hypernatraemia.
Pati D; Harden SW; Sheng W; Kelly KB; de Kloet AD; Krause EG; Frazier CJ
J Neuroendocrinol; 2020 Mar; 32(3):e12839. PubMed ID: 32133707
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic CRF neurons facilitate brain reward function.
Xu X; Zheng S; Ren J; Li Z; Li J; Xu Z; Yuan F; Yang Q; Margetts AV; Pollock TA; Vilca SJ; Yang C; Chen G; Shen P; Li S; Xia J; Chen C; Zhou T; Zhu Y; Tuesta LM; Wang L; Kenny PJ; Liu XA; Chen Z
Curr Biol; 2024 Jan; 34(2):389-402.e5. PubMed ID: 38215742
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors ERα and ERβ participation in hypothalamus-pituitary-adrenal axis activation by hemorrhagic stress.
Silva-Alves LM; Barcelos Filho PC; Franci CR
Neuroscience; 2017 May; 349():239-252. PubMed ID: 28279754
[TBL] [Abstract][Full Text] [Related]
18. Secretagogin Mediates the Regulatory Effect of Electroacupuncture on Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Surgical Trauma.
Zhang M; Sun J; Wang Y; Tian Z
Neural Plast; 2021; 2021():8881136. PubMed ID: 33628224
[TBL] [Abstract][Full Text] [Related]
19. Functional evidence that the nucleus of the hippocampal commissure shows an earlier activation from a stressor than the paraventricular nucleus: Implication of an additional structural component of the avian hypothalamo-pituitary-adrenal axis.
Nagarajan G; Kang SW; Kuenzel WJ
Neurosci Lett; 2017 Mar; 642():14-19. PubMed ID: 28137650
[TBL] [Abstract][Full Text] [Related]
20. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
